View Document Preview and Link
Open Document File Size: 47,56 KB Share Result on Facebook
City Beltsville / MSPAS / MACMIS / Kenilworth / / Company Valerie K. Cotler Schering Corporation / Global Labeling / Promotion Global Regulatory Affairs Schering Corporation / Roper / Schering Corporation / / Event FDA Phase / / / IndustryTerm treatment of the nasal symptoms / online survey / / MedicalCondition moderate-to-severe perennial allergic rhinitis / nasal polyps / perennial allergic rhinitis / nasal congestion / itching / Nasal allergy / allergic rhinitis / seasonal allergic rhinitis / seasonal and perennial allergic rhinitis / seasonal allergic and perennial allergic rhinitis / / Organization Food and Drug Administration / U.S. Food and Drug Administration / Division of Drug Marketing / Advertising / and Communications / DEPARTMENT OF HEALTH / / Person Nasonex / Michelle Safarik / / Position AM/PM / Officer / / Product fluticasone propionate / Nasonex / Flonase / mometasone furoate / I94-079 / Nasonex® / / ProvinceOrState New Jersey / Maryland / / SocialTag